![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 38/21 | (2006.01) |
A61K 9/00 | (2006.01) | ||
A61K 31/7056 | (2006.01) | ||
A61P 37/06 | (2006.01) |
(11) | Number of the document | 2026832 |
(13) | Kind of document | T |
(96) | European patent application number | 07729448.6 |
Date of filing the European patent application | 2007-05-23 | |
(97) | Date of publication of the European application | 2009-02-25 |
(45) | Date of publication and mention of the grant of the patent | 2012-05-02 |
(46) | Date of publication of the claims translation | 2012-07-25 |
(86) | Number | PCT/EP2007/055013 |
Date | 2007-05-23 |
(87) | Number | WO 2007/135172 |
Date | 2007-11-29 |
(30) | Number | Date | Country code |
06114537 | 2006-05-24 | EP | |
845470 P | 2006-09-18 | US |
(72) |
BRENTZEL, H., James, Jr., US
LOPEZ-BRESNAHAN, Maria, US
AMMOURY, Nazih, FR
|
(73) |
Merck Serono SA,
Centre Industriel, 1267 Coinsins, Vaud,
CH
|
(74) |
Marija LENKUTIENĖ,
Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
(54) | Interferono-beta ir kladribino derinio schema išsėtinės sklerozės gydymui |
COMBINATION OF INTERFERON-BETA AND A CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS |
Payment date | Validity (years) | Amount | |
2014-04-15 | 8 | 640.00 LTL |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2015-05-23 |